Get our latest issue now

available for iOS, Android & web

latest issue

Ex-Nycomed CEO to be Lundbeck chairman

Daily News | February 20, 2013

Kevin Grogan

Ex-Nycomed CEO to be Lundbeck chairman

Lundbeck says it will be electing a new chairman after its annual general meeting on March 21 where former chief executive of Nycomed, Hakan Bjorklund, will take over from Mats Pettersson.

Mr Pettersson, member of Lundbeck's board of directors since 2003 and chairman since 2011, has announced that he will not be seeking re-election. He said the company is "well-prepared to face the future, building on its strong platform for long-term growth, and I have decided that this was the right time to pass the baton to a new board member and chairman”.

Mr Bjorklund, who left Nycomed in 2011 after overseeing the sale of the company to Takeda, has been on the Lundbeck board for two years. He says the company “holds a unique and strong position in the development of pharmaceuticals for the treatment of brain disorders, which is one of the greatest health challenges of the 21st century".

Click here to order a reprint of this news story.


Your Comments

Tell us what you think.

Twitter Go to @PharmaTimes

Find a job

Website Search

Search News Search Magazine

Business Insight


Competitions News


International Clinical Researcher of the Year 2016

Book your tickets today!